1219409-06-9
1219409-06-9
Chemical Structure
Rebamipide-d4
Synonym(s): OPC12759-d4;Proamipide-d4
- CAS No.: 1219409-06-9
- Formula:C19H11D4ClN2O4
- Molecular Weight:374.81
IUPAC Name: 2-(4-chlorobenzamido-2,3,5,6-d4-2,3,5,6-d4)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid
InChIKey: ALLWOAVDORUJLA-KDWZCNHSSA-N
SMILES: OC(C(NC(C1=C([2H])C([2H])=C(Cl)C([2H])=C1[2H])=O)CC(C2=CC=CC=C2N3)=CC3=O)=O
Biological Activity: Rebamipide-d4 is deuterium labeled Rebamipide. Rebamipide is a mucoprotective agent. Rebamipide induces COX-2 expression, increases PGE2 levels, and enhances gastric mucosal defense in a COX-2-dependent manner[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Rebamipide-d4 | 99.0% | Rebamipide-d4 is deuterium labeled Rebamipide. Rebamipide is a mucoprotective agent. Rebamipide induces COX-2 expression, increases PGE2 levels, and enhances gastric mucosal defense in a COX-2-dependent manner. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Rebamipide (Standard) | 99.98% | Rebamipide (Standard) is the analytical standard of Rebamipide. This product is intended for research and analytical applications. Rebamipide (OPC12759) is an orally active gastroprotective agent that enhances the production of endogenous PGs (especially intragastric PGE2) by inducing COX-2 expression, thereby protecting the gastric mucosa from injury. Rebamipide exerts anti-proliferative activity against gastric cancer cells. Rebamipide can be used in studies of mucosal protection, gastroduodenal ulcer, gastritis and gastric cancer. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Rebamipide | 99.74% | Rebamipide (OPC12759) is an orally active gastroprotective agent that enhances the production of endogenous PGs (especially intragastric PGE2) by inducing COX-2 expression, thereby protecting the gastric mucosa from injury. Rebamipide exerts anti-proliferative activity against gastric cancer cells. Rebamipide can be used in studies of mucosal protection, gastroduodenal ulcer, gastritis and gastric cancer. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Structural Analogs
-
Similarity Score 0.89
HY-Z4185RRebamipide methyl ester (Standard) -
Similarity Score 0.87
HY-Z0629Rebamipide impurity 1 -
Similarity Score 0.87
HY-Z4445Rebamipide impurity 2 -
Similarity Score 0.84
HY-Z4184RRebamipide impurity 6 (Standard) -
Similarity Score 0.82
HY-Z0630RRebamipide impurity 3 (Standard) -
Similarity Score 0.80
HY-121278Benzotript -
Similarity Score 0.75
HY-109158Rebamipide mofetil -
Similarity Score 0.71
HY-41638R2-Acetylamino-3-(2-quinolon-4-yl)propionic acid (Standard) -
Similarity Score 0.62
HY-W0408042-Amino-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid hydrochloride -
Explore the MedChemAI to find more analogs
